drugset / Trial / NCT01206348

Combination Treatment for Moderate to Severe Acne

NCT01206348

Phase 4 Completed 97 enrolled Medicis Global Service Corporation
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine if a combination of three currently approved acne products are safe and effective for the treatment of moderate to severe acne

Timeline

Start
2010-09
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzoyl Peroxide Other / unclassified Topical
Subject Clindamycin Unknown Topical
Subject Minocycline Small molecule
Subject Tretinoin Small molecule Topical

Indications